362: Semiglutide, Ozempic and Majuro - Are these the Magic Obesity Solution? with Dr. Salas-Whalen
Midlife Conversations with Natalie Jill
Natalie Jill
4.8 • 607 Ratings
🗓️ 12 March 2024
⏱️ 32 minutes
🧾️ Download transcript
Summary
In this episode, you will learn:
- What's the deal with ozempic
- What are some components leading to obesity
- How do you know if you have type 2 diabities
- Are drugs an answer to weight loss and symptoms
Dr. Salas-Whalen is a triple board-certified physician with broad experience across all facets of endocrinology, with an emphasis on women’s health and obesity. She believes that every patient is different and that effective care must be customized according to individual needs. She is a strong advocate for patients’ quality of life. Also she aims more for prevention rather than treatment. She performs in-office thyroid ultrasonography and fine needle aspiration biopsy of thyroid nodules.
Dr. Salas-Whalen is an active participant in the continuing advancement of her field and a strong proponent of lifelong career learning.
Disclaimer: Information provided in the Midlife Conversations podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before making any changes to your current regimen.
Information provided in this podcast and the use of any products or services related to this podcast does not create a client-patient relationship between you and the host of Midlife Conversations or you and any doctor or provider interviewed and featured on this show. Information and statements may have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.
Advertising Disclosure: Some episodes of Midlife Conversations may be sponsored by products or services discussed during the show. The host may receive compensation for such advertisements or if you purchase products through affiliate links. Opinions expressed about products or services are those of the host and/or guests and do not necessarily reflect the views of any sponsor. Sponsorship does not imply endorsement of any product or service by healthcare professionals featured on this podcast.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | I've seen many patients that they may have a normal BMI and they have high percentage body |
| 0:05.6 | fat, they have high visceral fat that they will benefit from the medication, right? |
| 0:09.1 | That's one. |
| 0:10.0 | That by the simple eye, we cannot say who does and who doesn't need the medication. |
| 0:15.1 | Hi, I want to welcome you to Midlife Conversations. |
| 0:17.7 | I'm Natalie Jill, your host, and I help midlife women redefine and rebrand aging. |
| 0:22.7 | On this podcast, I do what I do best, taking complicated information and conversations around |
| 0:27.6 | aging that are relevant to us now and breaking it all down simply with actionable steps that |
| 0:33.2 | you can implement to level up your life, because your best years are yet to come. I also regularly |
| 0:38.7 | interview some of the most inspiring people living in their best midlife years. On this show, |
| 0:43.8 | I cover topics about our health, hormones, navigating weight, blood sugars, our mood, focus |
| 0:49.3 | changes, even our relationships, career changes, beauty, and more. |
| 1:00.6 | Today on Midlife Conversations, I've got Dr. Salas Whalen, who I've been following on social media. |
| 1:05.7 | She's triple board certified internal medicine, endocrinology, and obesity medicine. And what got my attention about her social media was talking about the trendy drug right now, OZempec, |
| 1:11.8 | the thing that everyone's accusing people that have lost weight of being on, the thing that's |
| 1:16.1 | also been helping a lot of people. I have so many questions. I am completely clueless when |
| 1:21.6 | it comes to this medication. So thank you so much for being here today. Thank you for inviting me. |
| 1:26.9 | Okay. So first and foremost, we know this is a |
| 1:29.3 | trendy topic right now, but how did this even become part of your practice? When did you make |
| 1:34.3 | this shift to going, I need to include this in my practice? I know you've been dealing with obesity for |
| 1:38.5 | years and years and years. So when I finished my fellowship in endocrinology, a new drug got approved was, |
| 1:47.0 | was named Bayera in 2005. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Natalie Jill, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Natalie Jill and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.